29 September 2022 | Other

Merck allows Sinopharm to sell its coronavirus drug in China

On Wednesday, a statement was released by drugmaker Merck & Co, according to which the company will allow the Chinese company Sinopharm to distribute and import the COVID-19 antiviral drug molnupiravir on China’s territory in case of its approval. 

Merck & Co announced the signing of a framework cooperation agreement with Sinopharm, under which the Chinese pharmaceutical corporation is granted the right to distribute and exclusivity of the rights to import a medicinal product to the Chinese market.

In addition, according to this statement, China National Biotec Group, which is a subsidiary of Sinopharm, will receive permission to manufacture this drug in China. In order to assist in this production, a technology transfer agreement has been carried out by Merck & Co.

In the United States, the molnupiravir sale is carried out under the brand name Lagevrio. After the development of this drug, profits were shared in equal measure between Merck and its partner Ridgeback Biotherapys.

Until Paxlovid, developed by one of Merck & Co's main competitors, the pharmaceutical company Pfizer Inc, became more widely used in the US due to showing the best results in clinical trials, the antiviral drug molnupiravir was promoted as a possible game-changer in the treatment of coronavirus infection.

Company MarketCheese
Brent sell
Period: 11.07.2025 Expectation: 400 pips
Brent falls ahead of OPEC+ decisions
04 July 2025 37
Period: 18.07.2025 Expectation: 900 pips
AUDCAD is likely to keep pulling back from its monthly high
04 July 2025 34
Period: 10.07.2025 Expectation: 1200 pips
Selling USDJPY during rebound with 142.430 target
03 July 2025 57
Period: 11.07.2025 Expectation: 220 pips
Heatwaves across Europe and US support gas price recovery from recent lows
03 July 2025 160
Period: 08.07.2025 Expectation: 1500 pips
EURUSD rally faces potential correction toward 1.165
02 July 2025 83
Period: 09.07.2025 Expectation: 1400 pips
USDCAD declines amid US dollar weakness and improving Canadian trade prospects
02 July 2025 57
Go to forecasts